-
Je něco špatně v tomto záznamu ?
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
P. Ljungman, R. de la Camara, C. Robin, R. Crocchiolo, H. Einsele, JA. Hill, P. Hubacek, D. Navarro, C. Cordonnier, KN. Ward, 2017 European Conference on Infections in Leukaemia group,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
ProQuest Central
od 2001-08-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2001-08-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2001-08-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2001-08-01 do Před 2 měsíci
- MeSH
- antivirové látky terapeutické užití MeSH
- benzimidazoly terapeutické užití MeSH
- cytomegalovirové infekce diagnóza etiologie prevence a kontrola MeSH
- Cytomegalovirus imunologie MeSH
- ganciklovir terapeutické užití MeSH
- hematologické nádory farmakoterapie MeSH
- leukemie komplikace farmakoterapie MeSH
- lidé MeSH
- ribonukleosidy terapeutické užití MeSH
- směrnice pro lékařskou praxi jako téma * MeSH
- transplantace hematopoetických kmenových buněk škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Cytomegalovirus is one of the most important infections to occur after allogeneic haematopoietic stem cell transplantation (HSCT), and an increasing number of reports indicate that cytomegalovirus is also a potentially important pathogen in patients treated with recently introduced drugs for hematological malignancies. Expert recommendations have been produced by the 2017 European Conference on Infections in Leukaemia (ECIL 7) after a review of the literature on the diagnosis and management of cytomegalovirus in patients after HSCT and in patients receiving other types of therapy for haematological malignancies. These recommendations cover diagnosis, preventive strategies such as prophylaxis and pre-emptive therapy, and management of cytomegalovirus disease. Antiviral drugs including maribavir and letermovir are in development and prospective clinical trials have recently been completed. However, management of patients with resistant or refractory cytomegalovirus infection or cytomegalovirus disease is a challenge. In this Review we summarise the reviewed literature and the recommendations of the ECIL 7 for management of cytomegalovirus in patients with haematological malignancies.
Department of Hematology Hospital de la Princesa Madrid Spain
Department of Microbiology School of Medicine University of Valencia Valencia Spain
Division of Infection and Immunity University College London London UK
Fred Hutchinson Cancer Research Center Seattle WA USA
Medizinische Klinik und Poliklinik 2 Julius Maximilians Universitaet Würzburg Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023787
- 003
- CZ-PrNML
- 005
- 20201214131203.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1473-3099(19)30107-0 $2 doi
- 035 __
- $a (PubMed)31153807
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ljungman, Per $u Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, and Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: per.ljungman@ki.se.
- 245 10
- $a Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7) / $c P. Ljungman, R. de la Camara, C. Robin, R. Crocchiolo, H. Einsele, JA. Hill, P. Hubacek, D. Navarro, C. Cordonnier, KN. Ward, 2017 European Conference on Infections in Leukaemia group,
- 520 9_
- $a Cytomegalovirus is one of the most important infections to occur after allogeneic haematopoietic stem cell transplantation (HSCT), and an increasing number of reports indicate that cytomegalovirus is also a potentially important pathogen in patients treated with recently introduced drugs for hematological malignancies. Expert recommendations have been produced by the 2017 European Conference on Infections in Leukaemia (ECIL 7) after a review of the literature on the diagnosis and management of cytomegalovirus in patients after HSCT and in patients receiving other types of therapy for haematological malignancies. These recommendations cover diagnosis, preventive strategies such as prophylaxis and pre-emptive therapy, and management of cytomegalovirus disease. Antiviral drugs including maribavir and letermovir are in development and prospective clinical trials have recently been completed. However, management of patients with resistant or refractory cytomegalovirus infection or cytomegalovirus disease is a challenge. In this Review we summarise the reviewed literature and the recommendations of the ECIL 7 for management of cytomegalovirus in patients with haematological malignancies.
- 650 _2
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 _2
- $a benzimidazoly $x terapeutické užití $7 D001562
- 650 _2
- $a Cytomegalovirus $x imunologie $7 D003587
- 650 _2
- $a cytomegalovirové infekce $x diagnóza $x etiologie $x prevence a kontrola $7 D003586
- 650 _2
- $a ganciklovir $x terapeutické užití $7 D015774
- 650 _2
- $a hematologické nádory $x farmakoterapie $7 D019337
- 650 _2
- $a transplantace hematopoetických kmenových buněk $x škodlivé účinky $7 D018380
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukemie $x komplikace $x farmakoterapie $7 D007938
- 650 12
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a ribonukleosidy $x terapeutické užití $7 D012263
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a de la Camara, Rafael $u Department of Hematology, Hospital de la Princesa, Madrid, Spain.
- 700 1_
- $a Robin, Christine $u Assistance Publique-Hopitaux de Paris, Department of Hematology, Henri Mondor Hospital and Université Paris-Est Créteil, Créteil, France.
- 700 1_
- $a Crocchiolo, Roberto $u Servizio Immunoematologia e Medicina Trasfusionale, Azienda Socio Sanitaria Territoriale di Bergamo Ovest, Treviglio, Italy.
- 700 1_
- $a Einsele, Hermann $u Medizinische Klinik und Poliklinik II, Julius Maximilians Universitaet, Würzburg, Germany.
- 700 1_
- $a Hill, Joshua A $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- 700 1_
- $a Hubacek, Petr $u Department of Medical Microbiology and Department of Paediatric Haematology and Oncology, Second Faculty of Medicine of Motol University Hospital and Charles University, Prague, Czech Republic.
- 700 1_
- $a Navarro, David $u Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
- 700 1_
- $a Cordonnier, Catherine $u Assistance Publique-Hopitaux de Paris, Department of Hematology, Henri Mondor Hospital and Université Paris-Est Créteil, Créteil, France.
- 700 1_
- $a Ward, Katherine N $u Division of Infection and Immunity, University College London, London, UK.
- 710 2_
- $a 2017 European Conference on Infections in Leukaemia group
- 773 0_
- $w MED00006437 $t The Lancet. Infectious diseases $x 1474-4457 $g Roč. 19, č. 8 (2019), s. e260-e272
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31153807 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214131201 $b ABA008
- 999 __
- $a ok $b bmc $g 1596106 $s 1114463
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 19 $c 8 $d e260-e272 $e 20190529 $i 1474-4457 $m Lancet. Infectious diseases $n Lancet Infect Dis $x MED00006437
- LZP __
- $a Pubmed-20201125
